Drugs / E6130
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03390647 | Dec 2017 → Mar 2019 | — | EA Pharma Co., Ltd. | Withdrawn | No outcome recorded |
| Phase 1 | NCT02902978 | Sep 2016 → Aug 2017 | — | EA Pharma Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | E6130 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03390647 ↗ |
| Route | Oral | “Oral dose” NCT03390647 ↗ |